Actively Recruiting
Application of 3D MR Neurogram for Intraparotid Facial Nerves Evaluation
Led by Chinese University of Hong Kong · Updated on 2026-04-03
50
Participants Needed
1
Research Sites
282 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Parotid neoplasm consists of a wide range of benign and malignant lesions, and parotidectomy has been the mainstay for management of these neoplasms. Within the parotid gland there are branches of the intra-parotid facial nerves, which are tiny in calibre and are prone to injury to injury during operation. It has been reported in recent retrospective view that the incidence of temporary and permanent facial nerve injury were 9.2% and 5.2% respectively, the risk of which increased with old age, malignant tumour and revision surgery. Traditional the incidental of facial nerve injury is reduced by intra-operative facial nerve monitoring and surgical magnification, while imaging has limited role in aiding this purpose. However with advancement in MRI technique high resolution three-dimensional sequences (i.e. neurogram sequences) are available for better visualization of branches of facial nerves. The investigators would therefore aim to demonstrate additional efficacy of these techniques and also to compare with conventional 3D post-contrast anatomical imaging studies in the localization and visualization of the facial nerve branches in patients with tumour. With better pre-operative imaging, the investigators hope to reduce the chance of facial nerve injury in these patients.
CONDITIONS
Official Title
Application of 3D MR Neurogram for Intraparotid Facial Nerves Evaluation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years or older
- Patients with a parotid tumor diagnosed by other imaging methods such as ultrasound or computed tomography, with or without a fine needle aspiration cytological diagnosis
- Patients recruited from the ear, nose, and throat specialty clinic
You will not qualify if you...
- Patients who cannot undergo MRI due to incompatible metallic implants
- Patients with contraindications to MRI contrast agents, such as advanced kidney failure or severe allergic reactions
- Patients unable to cooperate with MRI scanning
- Patients unable to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Gerald Choa MRI Center
Hong Kong, Hong Kong
Actively Recruiting
Research Team
G
Gerald Choa MRI Center CUHK
CONTACT
H
Ho Sang Leung, MBBS (HK)
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here